Person

Merdad Parsey

Formerly Chief Medical Officer, Gilead Sciences

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$22.2M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Nov 27, 2024GILDSale57,294$91.79$5.3M
Nov 27, 2024GILDSale10,399$92.00$957K
Nov 27, 2024GILDSale3,199$91.80$294K
Nov 27, 2024GILDSale5,200$91.80$477K
Nov 27, 2024GILDSale88,119$92.00$8.1M
Nov 6, 2024GILDSale20,590$91.50$1.9M
Nov 6, 2024GILDSale5,000$91.50$458K
Oct 1, 2024GILDSale2,000$83.83$168K
Sep 12, 2024GILDSale21,246$84.50$1.8M
Jul 1, 2024GILDSale2,000$68.63$137K
Apr 1, 2024GILDSale2,000$72.96$146K
Feb 29, 2024GILDSale8,230$72.74$599K
Feb 28, 2024GILDSale2,000$73.18$146K
Sep 12, 2023GILDSale1,501$76.99$116K
Jun 13, 2023GILDSale1,485$76.90$114K
Mar 13, 2023GILDSale6,126$78.99$484K
Mar 1, 2023GILDSale12,984$79.96$1.0M
Dec 30, 2022GILDSale553$85.33$47K
Aug 17, 2020GILDSale182$68.32$12K

SEC reporting-owner ID (CIK) 1792150 · all filings on EDGAR

Merdad Parsey | USBoard